Inhibition of mouse liver respiration by Chelidonium majus isoquinoline alkaloids

Toxicology Letters

Volumn 146, Issue 1, 2003, Pages 37-47

  Barreto, M Carmo ^a   Pinto, Ruy E ^b,c   Arrabaça, João D ^c   Pavão, M Leonor ^a  

^a UNIVERSITY OF THE AZORES   (Portugal)

^b INSTITUTO DE INVESTIGAÇÃO CIENTÍFICA BENTO DA ROCHA CABRAL   (Portugal)

^c UNIVERSITY OF LISBON   (Portugal)

Author keywords

Benzophenanthridine alkaloids; Mitochondrial respiration; NADH dehydrogenase; Protoberberine alkaloids; Structure activity relationship; Succinate dehydrogenase

Indexed keywords

BERBERINE; CHELERYTHRINE; COPTISINE; ISOQUINOLINE DERIVATIVE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; SANGUINARINE; SUCCINATE DEHYDROGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHELIDONIUM; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; MALE; MITOCHONDRIAL RESPIRATION; MOUSE; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL;

CHELIDONIUM MAJUS;

EID: 0242654822     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2003.09.007     Document Type: Article

References (26)

1. Bézanger-Beauquesne, L., Pinkas, M., Torck, M., Trotin, F., 1990. Plantes médicinales des régions tempérées, second ed. Ed. Maloine, Paris.
2. Bradford M.M. A rapid, sensitive method for the determination of protein concentrations using the Coomassie dye-binding. Anal. Biochem. 72:1976;248-254.
3. Cain, K., Skilleter, D.N., 1987. Preparation and use of mitochondria in toxicological research. In: Snell, K., Mullock, B. (Eds.), Toxicology: A Molecular Approach. IRL Press, Oxford, pp. 217-253.
4. + and NADH to the reduced enzyme form. FEBS Lett. 284:1991;192-194.
5. Colombo M.L., Bosisio E. Pharmacological activities of Chelidonium majus L. (Papaveraceae). Pharmacol. Res. 33:1996;127-134.
6. Dostál J., Potácek M. Quaternary benzo[c]phenanthridine alkaloids. Collect. Czech. Chem. Commun. 55:1990;2840-2871.
7. Duke, J., 1985. Handbook of Medicinal Herbs. CRC Press, London.
8. Harmon H.J., Hall J.D., Crane F.L. Structure of mitochondrial cristae membranes. Biochim. Biophys. Acta. 344:1974;119-155.
9. Kadan G., Gözler T., Shamma M. (-)-Turkiyenine, a new alkaloid from Chelidonium majus. J. Nat. Prod. 53:1990;531-532.
10. Lavenir R., Paris R.R. Sur les alcaloïdes de la chélidoine (Chelidonium majus L.): repartition dans divers organes, isolement de la stylopine a partir des fruits. Ann. Pharmaceut. Françaises. 23:1965;307-312.
11. Liu C., Xu J.X., Gu L.Q. Inhibition of succinate-ubiquinone reductase by nitrosalicyl-N-alkylamides. Biochim. Biophys. Acta. 1057:1991;373-376.
12. McNaught K.St.P., Thull U., Carrupt P.A., Altomare C., Cellamare S., Carotti A., Testa B., Jenner P., Marsden C.D. Inhibition of complex I by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP). Biochem. Pharmacol. 50:1995;1903-1911.
13. McNaught K.St.P., Thull U., Carrupt P.A., Altomare C., Cellamare S., Carotti A., Testa B., Jenner P., Marsden C.D. Effects of isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) on mitochondrial respiration. Biochem. Pharmacol. 51:1996;1503-1511.
14. Murphy M.P. Selective targeting of bioactive compounds to mitochondria. Tibtech. 15:1997;326-330.
15. Paris, R.R., Moyse, H., 1967. Précis de matière médicale, vol. II. Masson Ed., Paris, pp. 207-208.
16. Pavão M.L., Pinto R.E. Densitometric assays for the evaluation of water soluble alkaloids from Chelidonium majus L. (Papaveraceae) roots in the Azores, along one year cycle. Arquipélago, Sér. Ciências Biol. Marinhas. 13:1995;89-91.
17. Ramsay R.R., Singer T.P. Energy-dependent uptake of N-methyl-4- phenylpyridinium, the neurotoxic metabolite of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine, by mitochondria. J. Biol. Chem. 261:1986;7585-7587.
18. Ramsay R.R., Kowal A.T., Johnson M.K., Salach J.I., Singer T.P. The inhibition site of MPP+, the neurotoxic bioactivation product of 1-methyl-4-phenyl-1,2,3,5-tetrahydropyridine is near the Q-binding site of NADH dehydrogenase. Arch. Biochem. Biophys. 259:1987;645-649.
19. Schewe T., Müller W. Hemmung der Atmungskette durch die Alkaloïde Berberinsulfat, Alpinigenin und Tetrahydropalmatin. Acta Biol. Med. Ger. 35:1976;1019-1021.
20. Sedo A., Vlasicová K., Barták P., Vespalec R., Vicar J., Simánek V., Ulrichová J. Quaternary benzo[c]phenanthridine alkaloids as inhibitors of aminopetidase N and dipeptidyl peptidase IV. Phytother. Res. 16:2002;84-87.
21. Táborská E., Bochoráková H., Paulová H., Dostál J. Separation of alkaloids in Chelidonium majus by reversed phase HPLC. Planta Med. 60:1994;380-381.
22. Tomé F., Colombo M.L. Alkaloids from Chelidonium majus: distribution in the plant and factors affecting their accumulation. Phytochemistry. 40:1995;3-39.
23. Ulrichová J., Walterová D., Simánek V. Molecular mechanisms of the biological activity of quaternary benzophenanthridine and protoberberine alkaloids. Acta Univ. Palack. Olomuc. Fac. Med. 106:1984;31-38.
24. Ulrichová J., Dvorák Z., Vicar J., Lata J., Smrzová J., Sedo A., Sománek V. Cytotoxicity of natural compounds in hepatocyte cell culture models. The case of quaternary benzo[c]phenanthridine alkaloids. Toxicol. Lett. 125:2001;125-132.
25. Vallejos R.H., Rizzotto M.G. Effect of chelerythrine on mitochondrial energy coupling. FEBS Lett. 21:1972;195-198.
26. Xème Pharmacopée Française, 1989.